Samir Mehta's son Aman named MD of Torrent Pharma

MUMBAI: Torrent Pharma has named Aman Mehta , the older son of chairman Samir Mehta , as MD, solidifying the succession plan at the flagship of the $5.3 billion Torrent Group . His new role will begin on August 1. This appears to be the company’s first MD position.

Aman, 33, who represents the third generation of the family, joined the company's board as a director in 2022. His younger brother Shaan Mehta, 27, currently leads strategy at the company.

The Torrent Group, founded by Aman and Shaan’s grandfather in 1959, now has diverse interests spanning from pharmaceuticals to power. Their cousin, Jinal Mehta, currently serves as the vice chairman and MD of Torrent Power.

“ As part of our long-term strategic vision and succession planning, the board has approved the appointment of Aman Mehta as MD, effective August 1, 2025,” said Torrent Pharma, adding that “This appointment is aligned with our commitment to building a strong, future-ready leadership team capable of delivering sustainable value to all stakeholders.”

An economics graduate from Boston University with an MBA from Columbia University, Aman joined the Torrent Group in October 2013. His career spans leadership positions across the group's pharma and power businesses. A notable accomplishment includes overseeing the integration of Unichem's domestic operations into Torrent Pharma. The company acquired Unichem's 120 brands and manufacturing facility for Rs 3,600 crore in December 2017.